cycloheximide has been researched along with Adrenocortical Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, C; Clavey, V; Fruchart, JC; Hum, DW; Martin, G; Najib, J; Pilon, A; Staels, B; Vallé, M | 1 |
1 other study(ies) available for cycloheximide and Adrenocortical Carcinoma
| Article | Year |
|---|---|
Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Cortex; Adrenocortical Carcinoma; Binding Sites; CD36 Antigens; Cholesterol; Cholesterol Esters; Cyclic AMP-Dependent Protein Kinases; Cycloheximide; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lipoproteins, HDL; Lipoproteins, LDL; Membrane Proteins; Protein Binding; Receptors, Immunologic; Receptors, LDL; Receptors, Lipoprotein; Receptors, Scavenger; RNA, Messenger; Scavenger Receptors, Class B; Tumor Cells, Cultured | 1999 |